Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonsquamous Non Small Cell Lung Cancer”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05973773
What this trial is testing

REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)

Who this might be right for
Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Taiho Oncology, Inc. 285
Testing effectiveness (Phase 2)Looking for participantsNCT07252739
What this trial is testing

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04736173
What this trial is testing

Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNonsquamous Non Small Cell Lung CancerSquamous Non Small Cell Lung Cancer+1 more
Arcus Biosciences, Inc. 169
Large-scale testing (Phase 3)Study completedNCT04716933
What this trial is testing

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study

Who this might be right for
Nonsquamous Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 201
Large-scale testing (Phase 3)Study completedNCT00982111
What this trial is testing

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 633
Large-scale testing (Phase 3)UnknownNCT01656551
What this trial is testing

MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB
National Cancer Institute, Naples 232
Large-scale testing (Phase 3)Not Yet RecruitingNCT07383116
What this trial is testing

Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non Squamous Non-small Cell Lung Cancer
Shanghai Huaota Biopharmaceutical Co., Ltd. 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06028633
What this trial is testing

Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients

Who this might be right for
Advanced Non-squamous Non-small-cell Lung CancerRecurrent Non-Squamous Non-Small Cell Lung CancerMetastatic Non-squamous Non Small Cell Lung Cancer
Peking University First Hospital 28
Large-scale testing (Phase 3)Study completedNCT01017874
What this trial is testing

Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 236
Early research (Phase 1)Study completedNCT03846310
What this trial is testing

Evaluate Immunotherapy Combinations in Participants With Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer MetastaticNon Small Cell Lung CancerNonsquamous Nonsmall Cell Neoplasm of Lung+1 more
Arcus Biosciences, Inc. 77
Testing effectiveness (Phase 2)Ended earlyNCT02119650
What this trial is testing

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation 76
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Testing effectiveness (Phase 2)UnknownNCT03863483
What this trial is testing

Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy.

Who this might be right for
Nonsquamous Non-Small Cell Lung Cancer
Xin-Hua Xu 70
Large-scale testing (Phase 3)UnknownNCT03533127
What this trial is testing

LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer Recurrent
Luye Pharma Group Ltd. 648
Not applicableStudy completedNCT02420405
What this trial is testing

Mutation Detection of EBUS-TBNA Specimens Using NGS

Who this might be right for
Lung Cancer
Jiayuan Sun 78
Not applicableStudy completedNCT02679443
What this trial is testing

Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy

Who this might be right for
Lung AdenocarcinomaNeutropeniaAnemia+2 more
Post Graduate Institute of Medical Education and Research, Chandigarh 161
Testing effectiveness (Phase 2)UnknownNCT03062800
What this trial is testing

Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)

Who this might be right for
Advanced Nsclc
Qilu Hospital of Shandong University 232
Large-scale testing (Phase 3)Study completedNCT02578680
What this trial is testing

Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)

Who this might be right for
Non-Small-Cell Lung Carcinoma
Merck Sharp & Dohme LLC 616
Testing effectiveness (Phase 2)Ended earlyNCT02019979
What this trial is testing

Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IVNon-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Beth Israel Medical Center 14
Large-scale testing (Phase 3)Study completedNCT03829319
What this trial is testing

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)

Who this might be right for
Nonsquamous Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 761
Load More Results